Title: Distribution And Emergence Of Chloroquine-Resistant Plasmodium Vivax
Abstract:Plasmodium vivax is the second most geographically widespread human malaria parasite. The global burden of P. vivax malaria is approximately 70-80 million cases annually. Chloroquine given together wi...Plasmodium vivax is the second most geographically widespread human malaria parasite. The global burden of P. vivax malaria is approximately 70-80 million cases annually. Chloroquine given together with primaquine is currently the first-line treatment for P. vivax . P. vivax resistance to chloroquine has however been reported in several endemic areas, particularly Southeast Asia, the area with the greatest P. vivax burden. Emergence of chloroquine-resistant P. vivax (CRPV) imposes a significant impact on the control strategies and treatment policies in these endemic regions.Read More
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot